Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Dirnhofer

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Blood|January 12, 2013
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survivalGirish Venkataraman, Joo Y Song, Alexandar Tzankov, et al.
The Prostate|January 15, 2015
Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised miceChristian Wetterauer, Tatjana Vlajnic, Julia Schüler, et al.
Circulation Research|September 19, 2009
Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathyPrzemyslaw Blyszczuk, Gabriela Kania, Thomas Dieterle, et al.
Human Pathology|February 16, 2005
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemiaAlessandro Lugli, Monika Ebnoether, Sergio B Cogliatti, et al.
Human Pathology|February 1, 2008
Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approachBarbara Bernasconi, Eva Karamitopoulou-Diamantis, Eva Karamitopolou-Diamantiis, et al.
Hematological Oncology|October 29, 2021
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysisLuca Ceriani, Lisa Milan, Luciano Cascione, et al.
Hematological Oncology|August 17, 2018
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individualsAnnarita Conconi, Emanuele Zucca, Gloria Margiotta-Casaluci, et al.
The Journal of Experimental Medicine|July 13, 2016
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosisTakafumi Shimizu, Lucia Kubovcakova, Ronny Nienhold, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2013
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphomaMatthias Pfeifer, Michael Grau, Dido Lenze, et al.
Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Blood|January 12, 2013
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survivalGirish Venkataraman, Joo Y Song, Alexandar Tzankov, et al.
The Prostate|January 15, 2015
Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised miceChristian Wetterauer, Tatjana Vlajnic, Julia Schüler, et al.
Circulation Research|September 19, 2009
Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathyPrzemyslaw Blyszczuk, Gabriela Kania, Thomas Dieterle, et al.
Human Pathology|February 16, 2005
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemiaAlessandro Lugli, Monika Ebnoether, Sergio B Cogliatti, et al.
Human Pathology|February 1, 2008
Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approachBarbara Bernasconi, Eva Karamitopoulou-Diamantis, Eva Karamitopolou-Diamantiis, et al.
Hematological Oncology|October 29, 2021
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysisLuca Ceriani, Lisa Milan, Luciano Cascione, et al.
Hematological Oncology|August 17, 2018
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individualsAnnarita Conconi, Emanuele Zucca, Gloria Margiotta-Casaluci, et al.
The Journal of Experimental Medicine|July 13, 2016
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosisTakafumi Shimizu, Lucia Kubovcakova, Ronny Nienhold, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2013
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphomaMatthias Pfeifer, Michael Grau, Dido Lenze, et al.
Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Pageof 16